Micro Emerging Active

KOD stock surge: diabetic retinopathy results

New narrative with limited coverage — still forming.

Score
0.5
Velocity
▲ 1.0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Apr 12, 2026
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05) Neutral
Mar 28, 2026
Kodiak Sciences (KOD) Climbs 75% on Stellar Clinical Results Neutral

Timeline

First SeenMar 28, 2026
Last UpdatedMar 28, 2026